Concepedia

Anna Stankiewicz-Drogoń

AS

Statistics

Publications

8

Citations

246

H-Index

8

Active since

2006

Affiliations

Institute of Biochemistry and Biophysics, Polish Academy of Sciences(Current)

University of Warsaw

Warsaw University of Technology

Genomed (Poland)

Anna Stankiewicz-Drogoń is an author at Institute of Biochemistry and Biophysics, Polish Academy of Sciences specializing in antiviral therapy, molecular virology, and antiviral pharmacology.

ORCID

Publications per year

2006–2024

8

Publications

8

New acridone-4-carboxylic acid derivatives as potential inhibitors of Hepatitis C virus infection

Anna Stankiewicz-Drogoń, V. G. Kostina, I. V. Alexeeva et al. · Bioorganic & Medicinal Chemistry · 2008 · 56 citations

, , +12

Synthesis of New Acridone Derivatives, Inhibitors of NS3 Helicase, Which Efficiently and Specifically Inhibit Subgenomic HCV Replication

Anna Stankiewicz-Drogoń, Bernd Dörner, Thomas Erker et al. · Journal of Medicinal Chemistry · 2010 · 53 citations

, , +17

Searching for a new anti-HCV therapy: Synthesis and properties of tropolone derivatives

Anna Boguszewska‐Chachulska, Mariusz Krawczyk, Andżelika Najda et al. · Biochemical and Biophysical Research Communications · 2006 · 34 citations

, , +14

NS3 Peptide, a Novel Potent Hepatitis C Virus NS3 Helicase Inhibitor: Its Mechanism of Action and Antiviral Activity in the Replicon System

Agnieszka Gozdek, Igor Zhukov, Agnieszka Polkowska et al. · Antimicrobial Agents and Chemotherapy · 2007 · 32 citations

, , +17

Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: Identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication

Andżelika Najda-Bernatowicz, Mariusz Krawczyk, Anna Stankiewicz-Drogoń et al. · Bioorganic & Medicinal Chemistry · 2010 · 25 citations

, , +14

1–5 of 8